Organic electroluminescent materials and devices
US-11482683-B2 · Oct 25, 2022 · US
US12552986B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12552986-B2 |
| Application number | US-202217881372-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 4, 2022 |
| Priority date | Jun 20, 2016 |
| Publication date | Feb 17, 2026 |
| Grant date | Feb 17, 2026 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Iridium complexes comprising three different bidentate ligands and their use in OLEDs to enhance the device efficiency and lifetime are disclosed. The complexes have a structure of the formula Ir(L A )(L B )(L C ), where ligand L A is selected from a variety of structures, ligand L B has the structure and L C has the structure In these structures rings A, B, C, and D are each independently a 5 or 6-membered carbocyclic or heterocyclic ring; R 1 , R 2 , R 3 , R A , R B , R C , and R D can be any of a variety of substituents, and Z 1 and Z 2 are each independently C or N.
Opening claim text (preview).
The invention claimed is: 1 . A compound having a formula Ir(L A )(L B )(L C ) selected from wherein L A is the ligand with substituents R 1 , R 2 , and R 3 ; wherein L B is the ligand with substituents R A1 , R A2 , and R B ; wherein L C is the ligand with substituents R C and R D ; wherein R 1 , R 2 , R 3 , R A1 , R A2 , R B , R C , and R D each independently represents mono, to a maximum possible number of substitutions, or no substitution; wherein L A , L B , and L C are different from each other, and can be connected to each other to form multidentate ligand; wherein R 1 , R 2 , R 3 , R A1 , R A2 , R B , R C , and R D are each independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein any two or more substituents among R 1 , R 2 , R 3 , R A1 , R A2 , R B , R C , and R D are optionally joined or fused into a ring; and wherein at least one of the following is true: (i) at least one R 1 , R 2 , R 3 , R A , R A2 , R B , R C , or R D comprises a moiety selected from the group consisting of heteroalkyl, arylalkyl, alkoxy, aryloxy, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, partially or fully deuterated variants thereof, and partially or fully fluorinated variants thereof; or (ii) an R B is substituted or unsubstituted aryl or substituted or unsubstituted heteroaryl, and (a) the R B is joined with an adjacent R B that together with the ring coordinated to the Ir atom forms a dibenzofuran or aza-dibenzofuran moiety, or (b) at least one R A1 , R A2 , or R B is a partially or fully deuterated alkyl or partially or fully fluorinated alkyl. 2 . The compound of claim 1 , wherein at least two of R 1 , R 2 , R 3 , R A1 , R A2 , R B , R C , or R D are independently selected from the group consisting of alkyl, cycloalkyl, aryl, heteroaryl, partially or fully deuterated variants thereof, partially or fully fluorinated variants thereof, and combinations thereof. 3 . The compound of claim 1 , wherein at least one of L A , L B , and L C , is selected from the group consisting of: where i in Ai is 1 to 212 and the substituents in L a Ai , L c Ai , and L d Ai are defined as, L a Ai L c Ai , and L d Ai , where i is R 1a R 1b R 2 R 3a R 3b R 3c 1. H H H H H H 2. H CH3 H H H H 3. H CD3 H H H H 4. H C2H5 H H H H 5. H CD2CH3 H H H H 6. H CHMe2 H H H H 7. H CDMe2 H H H H 8. H H H H H 9. H H H H H 10. H H H H H 11. H H H H H 12. H H H H H 13. H
of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd · CPC title
with oxygen · CPC title
containing one nitrogen atom as the heteroatom · CPC title
non-luminescent particle coatings or suspension media · CPC title
Iridium compounds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.